Cerebral palsy (CP) encompasses various conditions affecting movement, posture, and motor skills, often necessitating lifelong care.
In the United States, CP affects approximately two to three children out of every 1,000. Research studies have reported rates ranging from 2.3 to 3.6 per 1,000 children.
Hyperbaric oxygen therapy (HBOT) has demonstrated potential in mitigating the effects of Cerebral Palsy (CP) in certain studies. Several forms of CP stem from oxygen deprivation to the brain during critical developmental stages—prior to birth, during delivery, or shortly after. Elevated oxygen levels have shown promise in rejuvenating or enhancing affected brain tissue. Various studies have reported positive outcomes with HBOT as a promising therapeutic approach for CP.
Several peer-reviewed, evidence-based studies have demonstrated the various benefits of hyperbaric oxygen therapy for individuals with cerebral palsy.
The information provided on this website is for educational purposes only and should not be viewed as a substitute for the diagnosis, treatment, or advice of a qualified licensed professional. This website offers general information and does not represent the practice of medicine. We do not take responsibility for how this information is utilized. Additionally, please note that the contents of this website are regularly updated for various reasons. Any statements or implied treatments have not been evaluated or approved by the FDA. It is crucial not to alter, discontinue, or change any medication or treatment without consulting your doctor first. Always seek your doctor’s advice before initiating any new treatment program.
In 2014, the Undersea Hyperbaric Medicine Journal published a controlled longitudinal study examining the effects of intensive rehabilitation coupled with hyperbaric oxygen therapy (HBOT) on gross and fine motor function in 150 children diagnosed with cerebral palsy.
During this eight-month study, each child received standard rehabilitation, with three groups also incorporating hyperbaric oxygen therapy (HBOT) into their treatment plan. The control group consisted of children who received standard rehabilitation alone without HBOT. All HBOT groups underwent 40 one-hour sessions, six days a week. The first HBOT group received treatment at 1.3 atmospheres absolute (ATA) with compressed air. The second HBOT group received treatment at 1.5 ATA with 100 percent oxygen delivered through a hood system, while the third HBOT group received treatment at 1.75 ATA, also with 100 percent oxygen delivered through a hood system.
“All four groups demonstrated improvements throughout the treatment period in the follow-up assessments (p < 0.001). However, the improvement in gross and fine motor function (GMFM) observed in the three hyperbaric groups was significantly greater compared to that in the control group (p < 0.001). There were no significant differences observed between the three hyperbaric groups.”
Learn about purchase and rental programs.
Copyright © 2024 Hyperbaric Hub LLC All Rights Reserved